More than 1000 mutations have been identified in the COL4A3, COL4A4, and COL4A5 genes leading to a reclassification of Alport syndrome and thin basement membrane nephropathy as type IV collagen nephropathies.14 This evidence concerns the gene COL4A5 and kidney disorder.